scholarly article | Q13442814 |
P356 | DOI | 10.1016/0021-9150(94)05498-8 |
P698 | PubMed publication ID | 7669086 |
P2093 | author name string | F B Smith | |
A J Lee | |||
A Rumley | |||
F G Fowkes | |||
G D Lowe | |||
P433 | issue | 1 | |
P921 | main subject | plasminogen | Q107129060 |
P304 | page(s) | 35-43 | |
P577 | publication date | 1995-05-01 | |
P1433 | published in | Atherosclerosis | Q4813570 |
P1476 | title | Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease | |
P478 | volume | 115 |
Q87411732 | Age and aerobic training status effects on plasma and skeletal muscle tPA and PAI-1 |
Q47764147 | Biologic markers as predictors of cardiovascular disease |
Q73025879 | Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta |
Q41559774 | Epidemiology of peripheral vascular disease |
Q35213428 | Exercise-induced changes in coagulation and fibrinolysis in healthy populations and patients with cardiovascular disease |
Q28658007 | Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. |
Q53345237 | Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators. |
Q22252221 | Obesity and Thrombosis |
Q34384926 | Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease |
Q34376916 | Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001. |
Search more.